Commercialization: Page
-
PharmaVoice Team/PharmaVoice
PharmaTrax
Converting Service Channels Into Sales Channels Promises Profit Growth Faced with escalating market demands to produce greater returns from existing corporate assets, executives at leading Fortune 500 organizations are increasingly converting traditional service channels into high-performance sal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Harnessing the Power of Blogs for Marketing Contributed by Scott Hagedorn In the digital world, we’ve been dealing with technological decentralization and the rise of the individual voice for a long time. Starting with bulletin boards (BBs) in the 1980s, then Websites, and now blogs, it has becom...
By Scott Hagedorn • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
January 2006 The Forum for the Industry Executive PharmaVOICE Gaining a Competitive Advantage Meeting Regulatory Requirements with Pamela Williamson Joyce Alzheimer’s Market Update Improving the Detail www.pharmavoice.com PharmaLinx Publication Volume 6, Number 1 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Alzheimer's Disease: Untangling the Brain's Mystery
By Cynthia Borda As the population ages, the prevalence of Alzheimer’s disease (AD) is expected to increase. But there is no real way to diagnose the disease and drugs currently on the market only treat the symptoms of Alzheimer’s. At the same time, analysts say there is tremendous opportunity fo...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents January 2006 On the Cover Competitive intelligence: The eyes and ears of the industry Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the factors that are creating a tougher environment for industry players and...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
HBA Unleashes the Power of Being
Becoming an Agent of Change Was the Focus of the 2005 Leadership Conference by Marie Tartaglio, M.Ed., Director, Training & Learning Strategy, Scientific Advantage LLC, and Donna Ramer, President, StrategCations Inc., Member, HBA Board of Directors “Successful leaders are adept at mastering c...
By Marie Tartaglio • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PharmaVOICE is pleased to present our annual Year in Preview issue. Our thanks to the more than 135 thought leaders who generously took the time to take stock of what they believe are the most-pressing issues the industry will face in the coming year. These hot trends address issues that will imp...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Ringing in a new year of change Taren Grom, Editor of PharmaVOICE, and Mary Alice Raudenbush, VP of Regulatory Affairs at Endo Pharmaceuticals, share a moment during the recent HBA Leadership Conference in Baltimore, the focus of which was becoming an agent of change. HBA Leadership Conference Ri...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The New Detail: Creating Value
Preserving access for representatives with physicians and creating win-win relationships are two major challenges facing the industry, but opportunities exist for creative people committed to healthcare and the value of medicine. The new reality of medical practice is that time is a very limited ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Tracking the Trends: The Industry Across Sectors
From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry executives, representing all of the major sectors of the life-sciences industry, provide their insights on the ...
By Taren Grom and Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Doctors' Choice Awards
Journal Advertising A Powerful Medium November 2005 According to experts at the AMP, the high level of physicians’ responses to this year’s TDC reaffirms the role medical journal advertising plays as an information source for physicians about pharmaceutical products. Medical journal advertising r...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays tribute to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single bran...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Wilson Learning Enhances Performance Measurement Solution Wilson Learning Corp. has released an enhanced version of its Leader Navigator performance measurement system, a multi-rater, 360-degree tool that provides personalized fee...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
About EDC: Michael Minor says EDC has a significant place in global data management strategies. Year In Preview From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Year in Preview 2006 More than 135 experts talk about the industry’s future The Forum for the Industry Executive December 2005 Special Issue www.pharmavoice.com December 2005 PharmaVoice Volume 5 • Number 12 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Year in Preview -- Featured Experts
Featured Experts Indexed by Section Introduction Introduction Murray Aitken. IMS Health Rudy Bakalov, CISSP. Ernst & Young LLP Daniel B. Carr, M.D. Javelin Pharmaceuticals Inc. Mark A. Goldberg, M.D. Perceptive Informatics, Parexel International Cort Grey. Dendrite Clinical Travis Hollingswor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Competitive Intelligence: The Eyes and Ears of the Industry
The need to gain a competitive advantage has never been greater, and competitive-intelligence (CI) teams are evolving to meet the industry’s current and future challenges. Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the fact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
In the Clinic: Trials & Tribulations
Stakeholders involved with drug development and the clinical-trial process are rising to the challenges to improve efficiencies, reduce costs, and accelerate time lines. Systematic elegant approaches borrowing from areas such as intelligence analysis are at hand. Enhanced product characterization...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Year in Preview -- Thought Leaders
Thought Leaders Listed in Alphabetical Order December 2005 Year in Preview 2006 Meredith Abreu. VP of Research, Manhattan Research LLC, New York; Manhattan Research is a provider of health and pharmaceutical marketing research and strategic analysis. For more information, visit manhattanresearch....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
In the Boardroom
From defining and redefining organizational business models for big pharma, biotech, and emerging pharma to tactical decisions related to developing generic defense strategies to improving communications and corporate reputation plans to grappling with technology issues, today’s pharmaceutical le...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integrated Marketing Communications: Understanding the Premise, Fulfilling the Promise
Integrated Marketing Communications: Understanding the Premise, Fulfilling the Promise Gary Bridi, Managing Director, S&H NJ Integrated marketing communications (IMC) is not a new idea. But while it has been discussed in academic and industry circles since the early 90s, its full benefi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What Do You Look for in a Widget?
What Do You Look for in a Widget? Warren A. Dardine President, Clinical Education Associates, a division of Dimensional HealthCare Inc. Suppose you were in the market to buy a new widget. You would probably read manufacturer information regarding the superiority of the newer widget compar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pharma's Opportunity: Branding for the Long Haul
Branding Pharma’s Opportunity: Branding for the Long Haul By Kristen Spensieri The vital importance of branding has long been standard practice in the consumer marketplace, with the most successful companies creating brands that stand for infinitely more than individual products or, in som...
By PharmaVoice Team • Jan. 2, 2008
Previous
